Recurrently deregulated lncRNAs in hepatocellular carcinoma
2017 · Nature Communications · 378 citations
https://doi.org/10.1038/ncomms14421
H
Hongyang Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
933
Papers
34.9K
Citations
96
h-index
374
i10-index
Hongyang Wang is an academic researcher from Qingdao University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatitis B Virus Studies & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 96, co-authored 794 publications.
ORCID: 0000-0002-4709-3334Papers by this author
worksThe gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis
2020 · Nature · 352 citations
https://doi.org/10.1038/s41586-020-2183-2
Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma
2019 · Theranostics · 322 citations
https://doi.org/10.7150/thno.32796
Role of nonresolving inflammation in hepatocellular carcinoma development and progression
2018 · npj Precision Oncology · 291 citations
https://doi.org/10.1038/s41698-018-0048-z
GWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers
2012 · PLoS Genetics · 204 citations
https://doi.org/10.1371/journal.pgen.1002791
Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2
2018 · npj Precision Oncology · 168 citations
https://doi.org/10.1038/s41698-017-0044-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat